Pillarstone completes first Greek transaction
Pillarstone, the pan-European platform to support banks in managing exposures to non-core and underperforming assets, has announced that Famar will be the first transaction of its Greek platform.
Famar is announcing our participation at CPhI NA 2017
We are excited to announce our participation in one more top event of the pharmaceutical industry, CPhI North America.
FAMAR expands manufacturing footprint into North America
Famar today announces the closing of the acquisition of a manufacturing site from Bayer, located at Pointe-Claire, Canada, with the transfer of full ownership of the plant to Famar.
Famar is announcing our participation at D-CAT Week 2017
As part of Famar’s growth strategy and offering new business opportunities to its customers, we are excited to announce our participation at D-CAT Week 2017
Famar announces its acquisition of Pointe Claire
Famar announces the acquisition of their first manufacturing site in North America
Ecovadis 2016 Assessment
Pleased to announce that Famar Group has been awarded for the 2nd consecutive year at the Silver level by Ecovadis
Ecovadis Gold Recognition
Ecovadis Gold Recognition for two Famar sites
FAMAR in CPhI 2015
FAMAR will be participating in CPhI 2015 in Madrid
FAMAR Netherlands realising an important milestone
Famar Netherlands in Bladel, specialized in liquid pharmaceutical and cosmetics production, is offering a range of capabilities for creams, emulsions, ointments, solutions, syrups and suspensions. As of the 1st of June Famar Bladel realised an important milestone in their master plan, with a production area expansion by 18% and the opening of a new Cosmetics area. To support this expansion, 240 m² office space and 240 m² old packaging area were transformed into a refurbished cosmetic area of 630 m². Two existing lines will be installed in this new area enabling Bladel to work under competitive cosmetic conditions.
Silver Recognition awarded to Famar by Ecovadis
Famar has been awarded "Silver Recognition Level" following the first assessment conducted by Ecovadis in January 2015...